Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma

Minimal residual disease (MRD) monitoring by PCR methods is a strong and standardized predictor of clinical outcome in mantle cell lymphoma (MCL) and follicular lymphoma (FL). However, about 20% of MCL and 40% of FL patients lack a reliable molecular marker, being thus not eligible for MRD studies....

Descripción completa

Detalles Bibliográficos
Autores principales: Genuardi, Elisa, Klous, Petra, Mantoan, Barbara, Drandi, Daniela, Ferrante, Martina, Cavallo, Federica, Alessandria, Beatrice, Dogliotti, Irene, Grimaldi, Daniele, Ragaini, Simone, Clerico, Michele, Lo Schirico, Mariella, Saraci, Elona, Yilmaz, Mehmet, Zaccaria, Gian Maria, Cortelazzo, Sergio, Vitolo, Umberto, Luminari, Stefano, Federico, Massimo, Boccadoro, Mario, van Min, Max, Splinter, Erik, Ladetto, Marco, Ferrero, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451873/
https://www.ncbi.nlm.nih.gov/pubmed/33742718
http://dx.doi.org/10.1002/hon.2864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451873/
https://www.ncbi.nlm.nih.gov/pubmed/33742718
http://dx.doi.org/10.1002/hon.2864

Ejemplares similares